CKD patients are generally in a state of low-grade chronic inflammation, with persistent elevations of inflammatory markers, such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), observed in these patients (38, 52). This evidence concerns the gene IL6 and chronic kidney disease.